Tag Archives: Obamacare

Despite Growing Momentum, Repeal of Medical Device Tax Faces Significant Hurdles

by William Kitchens On March 21, 2013, the United States Senate approved an amendment by a vote of 79 to 20 to repeal the 2.3 percent medical device excise tax. The tax, which went into effect this past January, was included as part of the Patient Protection and Affordable Care Act.
Posted in Strategy | Also tagged , , , , | Leave a comment

Are US and Canadian Rx Policies Converging?

by Tom Norton As the US pharmaceutical industry anxiously watches the rapid onset of Obamacare, certainly one of the more pressing issues is the debate over the number of drugs that will be reimbursed in each therapeutic class under the Essential Health Benefits (EHB) program.  To say that this is a critical concern for the future [...]
Posted in Global, Guest Blog, Legal, Market Access, Strategy, healthcare | Also tagged , , , , , | Leave a comment

State Surprises as Obamacare Starts Up

by Tom Norton This past week or so, with Obamacare’s start up less than a year away, we have been treated to several entertaining vignettes as the nation’s governors begin to wrestle with the realities of the new healthcare law.  
Posted in Guest Blog, Legal, Strategy, healthcare, leadership | Also tagged , , , , , , , | Leave a comment

Questions About the 2013 Implementation of IPAB

by Tom Norton With the general election behind us, the anticipated avalanche of ObamaCare regulations has begun.  Last week, it was reported that more than 13,000 pages of rules and regulations have been issued by HHS since Nov. 6th.   A huge amount of activity, to be sure, but as stated, not surprising.  That’s because the law [...]
Posted in FDA, Legal, Market Access, Regulatory, healthcare, pricing | Also tagged , , , , , , | Leave a comment

With the Election Decided, It's Full Speed Ahead on ObamaCare

by Tom Norton With the Presidential election decided and President Obama the clear winner, it’s time for Pharma to get down to business on the implementation of ObamaCare.  Here are some of the key actions to anticipate between now and January 1, 2013.
Posted in FDA, Legal, Regulatory, Strategy, healthcare | Also tagged , , , , , | 3 Comments